| All | ART (−) patients | ART (+) patients |  |  | |||
---|---|---|---|---|---|---|---|---|
 | n | % | n | % | n | % | Pvalues |  |
Total* | 225 | 100.0% | 136 | 100.0% | 66 | 100.0% | Â | Â |
Malignant lymphoma | 50 | 22.2% | 33 | 24.3% | 16 | 24.2% | 0.997 | Â |
Cytomegalovirus | 44 | 19.6% | 27 | 19.9% | 9 | 13.6% | 0.279 | Â |
Pneumonia | 31 | 13.8% | 19 | 14.0% | 9 | 13.6% | 0.949 | Â |
Pneumocystis jirovecii pneumonia | 30 | 13.3% | 21 | 15.4% | 4 | 6.1% | 0.058 | Â |
Non-tuberculous mycobacterium | 12 | 5.3% | 10 | 7.4% | 2 | 3.0% | 0.367 | Y |
Kaposi sarcoma | 11 | 4.9% | 7 | 5.1% | 2 | 3.0% | 0.749 | Y |
Progressive multifocal leukoencephalopathy | 8 | 3.6% | 4 | 2.9% | 2 | 3.0% | 0.684 | Y |
Cancer | 8 | 3.6% | 2 | 1.5% | 6 | 9.1% | 0.026 | Y |
Hepatitis | 8 | 3.6% | 3 | 2.2% | 4 | 6.1% | 0.320 | Y |
Cryptococcus | 7 | 3.1% | 6 | 4.4% | 0 | 0.0% | 0.197 | Y |
Kidney failure | 7 | 3.1% | 4 | 2.9% | 3 | 4.5% | 0.861 | Y |
HIV encephalopathy | 7 | 3.1% | 5 | 3.7% | 2 | 3.0% | 0.861 | Y |
Aspergillus | 6 | 2.7% | 5 | 3.7% | 0 | 0.0% | 0.274 | Y |
Toxoplasmosis | 4 | 1.8% | 3 | 2.2% | 1 | 1.5% | 0.835 | Y |
Tuberculosis | 3 | 0.9% | 2 | 1.5% | 0 | 0.0% | 0.816 | Y |
Sepsis | 3 | 1.3% | 2 | 1.5% | 1 | 1.5% | 0.551 | Y |
Candida | 3 | 1.3% | 2 | 1.5% | 0 | 0.0% | 0.816 | Y |
Varicella zoster virus | 2 | 1.3% | 1 | 0.7% | 1 | 1.5% | 0.816 | Y |
Nocardia | 1 | 0.4% | 1 | 0.7% | 0 | 0.0% | 0.711 | Y |
Histoplasma | 1 | 0.4% | 1 | 0.7% | 0 | 0.0% | 0.711 | Y |